View
Semantic Search: Come Follow the Lilly Earnings Call With Me
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.845
· Account tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z ---------- Forwarded message ---------- From: Dave Knapp from On The Pen <onthepen@substack.com> Date: Apr 30, 2026 at 9:42 AM -0400 To: tjphuhs@gmail.com Subject: Come Follow the Lilly Earnings Call With Me > Lilly earnings are this morning. > ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.845
· Account oc.tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z ---------- Forwarded message ---------- From: Dave Knapp from On The Pen <onthepen@substack.com> Date: Apr 30, 2026 at 9:42 AM -0400 To: tjphuhs@gmail.com Subject: Come Follow the Lilly Earnings Call With Me > Lilly earnings are this morning. > ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Come Follow the Lilly Earnings Call With Me
Score 0.827
· Account tjphuhs@gmail.com
· 4/30/2026, 9:42:29 AM
Come Follow the Lilly Earnings Call With Me from onthepen@substack.com on 2026-04-30T13:42:29.000Z View this post on the web at https://onthepen.substack.com/p/come-follow-the-lilly-earnings-call Lilly earnings are this morning. I’ll be live tweeting my instant reactions on X. Real-time updates, for those who can’t listen… This is going to be an interesting call with lots of pipeline discussion! 👉 Follow along here Later today I’ll be dropping my video roundup, the full picture, and what it mea
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.793
· Account tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z · Apr 30, 2026 · 28 Views > 1 Like > Later today I’ll be dropping my video roundup, the full picture, and what it means for patients... > Here are my two favorite slides to look at for what’s upcoming in obesity medicine: > VISIT OUR SPONSORS! > You’re currently a free subscriber to On The Pen. For premium access to insider articles, upgrade to paid. > Upgrade to paid > > Share > > > Like > Commen
Fwd: Come Follow the Lilly Earnings Call With Me
Score 0.793
· Account oc.tjphuhs@gmail.com
· 4/30/2026, 11:00:39 AM
Fwd: Come Follow the Lilly Earnings Call With Me from tjphuhs@gmail.com on 2026-04-30T15:00:39.000Z · Apr 30, 2026 · 28 Views > 1 Like > Later today I’ll be dropping my video roundup, the full picture, and what it means for patients... > Here are my two favorite slides to look at for what’s upcoming in obesity medicine: > VISIT OUR SPONSORS! > You’re currently a free subscriber to On The Pen. For premium access to insider articles, upgrade to paid. > Upgrade to paid > > Share > > > Like > Commen
What Lilly’s Earnings Call Just Revealed About the Future of Obesity Treatment
Score 0.719
· Account tjphuhs@gmail.com
· 4/30/2026, 1:08:23 PM
What Lilly’s Earnings Call Just Revealed About the Future of Obesity Treatment from onthepen@substack.com on 2026-04-30T17:08:23.000Z View this post on the web at https://onthepen.substack.com/p/what-lillys-earnings-call-just-revealed There was a moment in this call for me where all of the incredibly impressive numbers stopped meaning much to me, and the structure underneath them started to matter a lot more. Lilly reported $12.8 billion in combined revenue for Mounjaro and Zepbound, with prescr
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Score 0.677
· Account tjphuhs@gmail.com
· 3/13/2026, 5:29:55 PM
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge from onthepen@substack.com on 2026-03-13T21:29:55.000Z NEW STUDIO WE ARE BUILDING. EVERY DOLLAR MADE BETWEEN NOW AND OUR LAUNCH WILL GO TOWARDS HELPING US TURN THIS INTO THE FIRST EVER PRODUCTION STUDIO DEDICATED TO OBESITY MEDICINE NEWS. IF YOU BELIEVE IN IT, CONSIDER “PUTTING YOUR NAME ON IT” TODAY! Unsubscribe https://substack.com/redirect/2/eyJlIjoiaHR0cHM6Ly9vbnRoZXBlbi5zdWJzdGFjay5jb20vYWN0aW9uL2Rpc2FibGVfZW1haWw_d
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Score 0.619
· Account tjphuhs@gmail.com
· 3/13/2026, 5:29:55 PM
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge from onthepen@substack.com on 2026-03-13T21:29:55.000Z View this post on the web at https://onthepen.substack.com/p/lilly-flags-new-court-ruling-as-telehealth Eli Lilly quietly filed a Statement of Recent Decision this week in its lawsuit against Mochi Health, pointing the judge to a recent federal ruling that could influence how the case proceeds. The move is procedural but strategic, and it signals that the pharmaceuti
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.618
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z ---------- Forwarded message ---------- From: Derek from Research Radar <derekpruski@substack.com> Date: Apr 24, 2026 at 9:10 AM -0400 To: tjphuhs@gmail.com Subject: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine > Let’s talk about one of the biggest stories currently brewing in the obesity and metabolic disease space — Eli Lilly’s rumored quintup
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.618
· Account tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z ---------- Forwarded message ---------- From: Derek from Research Radar <derekpruski@substack.com> Date: Apr 24, 2026 at 9:10 AM -0400 To: tjphuhs@gmail.com Subject: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine > Let’s talk about one of the biggest stories currently brewing in the obesity and metabolic disease space — Eli Lilly’s rumored quintup
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge
Score 0.597
· Account tjphuhs@gmail.com
· 3/13/2026, 5:29:55 PM
Lilly Flags New Court Ruling as Telehealth GLP-1 Lawsuits Begin to Converge from onthepen@substack.com on 2026-03-13T21:29:55.000Z is important because federal courts have historically been cautious about stepping into disputes that fall within the FDA’s enforcement authority. In several previous cases involving pharmaceutical marketing claims, judges have ruled that questions about drug labeling and promotional language are issues that regulators, not courts, are typically responsible for polic
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.596
· Account tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z > • > News-Medical coverage: “New quintuple agonist shows promise for treating obesity and type 2 diabetes.” September 21, 2025. news-medical.net > • > Andreassen KV, et al. Research on Dual Amylin and Calcitonin Receptor Agonists (DACRAs, KBP-042, KBP-089) — various publications > • > Eli Lilly pipeline page (no quintuple currently listed): lilly.com/science/research-de
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.596
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z > • > News-Medical coverage: “New quintuple agonist shows promise for treating obesity and type 2 diabetes.” September 21, 2025. news-medical.net > • > Andreassen KV, et al. Research on Dual Amylin and Calcitonin Receptor Agonists (DACRAs, KBP-042, KBP-089) — various publications > • > Eli Lilly pipeline page (no quintuple currently listed): lilly.com/science/research-de
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.595
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z still mouse data Mouse-to-market is typically 8-12 years Retatrutide is what’s actually arriving soon Eloralintide is what’s actually advancing through Phase 3 for amylin The quintuple, if real, is a late-decade story The most important thing to do right now is stay curious and stay patient. Let the science play out. Don’t build expectations around compounds that haven
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.592
· Account tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z be a quintuple before that is a scam > > ═══════════════════════════════ > BOTTOM LINE > The progression from dual to triple to quintuple is one of the most exciting trajectories in modern metabolic medicine. > What makes the quintuple concept interesting: > > • > Each receptor in the rumored stack solves a distinct problem > • > The mechanisms are complementary, not red
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.592
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z be a quintuple before that is a scam > > ═══════════════════════════════ > BOTTOM LINE > The progression from dual to triple to quintuple is one of the most exciting trajectories in modern metabolic medicine. > What makes the quintuple concept interesting: > > • > Each receptor in the rumored stack solves a distinct problem > • > The mechanisms are complementary, not red
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.590
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z control (the tirzepatide backbone) Adding glucagon brings fat-burning and energy expenditure (the retatrutide upgrade) Adding amylin brings extended satiety and slowed gastric emptying from a different pathway Adding calcitonin brings longer-duration satiety, insulin sensitivity, and bone/joint protection On paper, you’d be combining the best of everything that’s alrea
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.586
· Account oc.tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z and GIP give core appetite and blood sugar control (the tirzepatide backbone) > • > Adding glucagon brings fat-burning and energy expenditure (the retatrutide upgrade) > • > Adding amylin brings extended satiety and slowed gastric emptying from a different pathway > • > Adding calcitonin brings longer-duration satiety, insulin sensitivity, and bone/joint protection > > O
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.586
· Account tjphuhs@gmail.com
· 4/24/2026, 9:42:34 AM
Fwd: Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from tjphuhs@gmail.com on 2026-04-24T13:42:34.000Z and GIP give core appetite and blood sugar control (the tirzepatide backbone) > • > Adding glucagon brings fat-burning and energy expenditure (the retatrutide upgrade) > • > Adding amylin brings extended satiety and slowed gastric emptying from a different pathway > • > Adding calcitonin brings longer-duration satiety, insulin sensitivity, and bone/joint protection > > O
Last Call For BIG Easter Savings...
Score 0.580
· Account tjphuhs@gmail.com
· 4/8/2026, 1:28:53 PM
Last Call For BIG Easter Savings... from hello@pctz.news on 2026-04-08T17:28:53.000Z FOR 10% OFF This offer is valid until tomorrow, so don't let the chance to save slip away! Click the link below to browse our website and stock up on your favorite meds at the best possible prices... PCTZONE © Copyright, 2026, • You received this email because you are subscribed to newsletters from . Unsubscribe
TAP US Private Equity Fund of Funds (USPE) is now on Robinhood
Score 0.576
· Account tjphuhs@gmail.com
· 4/21/2026, 12:52:03 PM
TAP US Private Equity Fund of Funds (USPE) is now on Robinhood from noreply@robinhood.com on 2026-04-21T16:52:03.000Z style="font-family:Helvetica, Arial;font-size:15px;line-height:25px;text-align:left;color:#6F787E;">– The Robinhood team</div></td></tr><tr><td align="left" style="font-size:0px;padding:12px 0px;padding-top:0;padding-bottom:22px;word-break:break-word;"><div style="font-family:Helvetica, Arial;font-size:15px;line-height:25px;text-align:left;color:#040D14;"></div></td></tr></tbody>
Will Tesla shareholders take off for SpaceX stock?
Score 0.576
· Account tjphuhs@gmail.com
· 5/11/2026, 6:43:54 AM
Will Tesla shareholders take off for SpaceX stock? from hello@snacks.robinhood.com on 2026-05-11T10:43:54.000Z options data from 6 US exchanges, helping individual investors tap into market sentiment. Read the 5-min explainer here . Ad   Snack Fact of the Day Searches for last-minute flowers spike annually around Valentine’s Day and Mother’s Day.   This Week Monday: Premarket earnings: Circle , Constellation Energy , KKR & Co. , Mosaic Co. , and Fox Corp. Postmarket earnings: Hims &
April Showers of Savings ☔ 60% Off TRUE METRIX® Glucose Test Strips
Score 0.575
· Account tjphuhs@gmail.com
· 4/30/2026, 10:15:56 AM
April Showers of Savings ☔ 60% Off TRUE METRIX® Glucose Test Strips from customer-service@e.totaldiabetessupply.com on 2026-04-30T14:15:56.000Z Free Shipping On Orders of $79 or More! Ends Soon April Showers Of Savings 60% Off TRUE METRIX Glucose Test Strips - 30 Ct. 60% Off TRUE METRIX Glucose Test Strips - 30 Ct. Our April Showers of Savings event ends soon! Enjoy our final mystery discounts every day until May 1st. With a deal no one should miss, toda
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine
Score 0.572
· Account tjphuhs@gmail.com
· 4/24/2026, 9:05:46 AM
Eli Lilly’s Quintuple Agonist: The Next Frontier in Metabolic Medicine from derekpruski@substack.com on 2026-04-24T13:05:46.000Z single dose and push efficacy into territory that previously only bariatric surgery could reach. ═══════════════════════════════ THE FIVE RECEPTORS AND WHY EACH MATTERS The rumored Lilly quintuple reportedly targets GLP-1, GIP, glucagon, amylin, and calcitonin. Let’s break down what each one actually does. GLP-1 (Glucagon-Like Peptide-1) This is the backbone of every m
TAP US Private Equity Fund of Funds (USPE) is now on Robinhood
Score 0.569
· Account tjphuhs@gmail.com
· 4/21/2026, 12:52:03 PM
TAP US Private Equity Fund of Funds (USPE) is now on Robinhood from noreply@robinhood.com on 2026-04-21T16:52:03.000Z width="652" bgcolor="#ffffff" ><tr><td style="line-height:0px;font-size:0px;mso-line-height-rule:exactly;"><![endif]--><div class="bodyText mj-section-rh" style="background:#ffffff;background-color:#ffffff;margin:0px auto;max-width:652px;"><table align="center" border="0" cellpadding="0" cellspacing="0" role="presentation" style="background:#ffffff;background-color:#ffffff;width: